US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.47

+0.07000.19%

Post-market: 37.470.00000.00%19:48 EDT

Volume:586.07K

Turnover:21.97M

Market Cap:833.71M

PE:- -

High:37.86

Open:37.60

Low:37.42

Close:37.40

52wk High:38.19

52wk Low:28.26

Shares:22.25M

Float Shares:22.25M

Volume Ratio:4.12

T/O Rate:2.63%

Dividend:0.23

Dividend Rate:0.62%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Tellgen Corporation Secures Six New Medical Device Approvals

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit

Actinogen Plans Major Share Placement to Bolster Funding Capacity

Incyte Reaches CMS Pact on Jakafi Medicaid Pricing

Teva to lower cost of select medicines for American patients covered by Medicaid

Here's How to Invest Using a Winning Strategy That Offers a Spin on Traditional Stock Index Funds

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

SomnoMed Tightens Insider Trading Rules With New Securities Policy

Recombinant Collagen Leader Faces Growth Challenges After Weak Interim Results

Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty

Roche receives FDA approval for companion diagnostic tests for Ziihera

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/RSPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.47,"timestamp":1788292800000,"preClose":37.4,"halted":0,"volume":586069,"hourTrading":{"tag":"盘后","latestPrice":37.47,"preClose":37.47,"latestTime":"19:48 EDT","volume":19,"amount":712.74,"timestamp":1788306513984,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.001871657754010703,"floatShares":22250000,"shares":22250000,"eps":0,"marketStatus":"Closed","change":0.07,"latestTime":"09-01 16:00:00 EDT","open":37.6,"high":37.86,"low":37.42,"amount":21974242.804217,"amplitude":0.011765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":37.4,"sharesOutstanding":23410000,"nav":37.40491,"aum":837121885.8,"dividendRate":0.006194,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":37.4,"preClose":37.4,"latestTime":"08:41 EDT","volume":1,"amount":37.4,"timestamp":1788266513762,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.47,"preClose":37.47,"latestTime":"19:48 EDT","volume":19,"amount":712.74,"timestamp":1788306513984,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":4.12041,"impliedVol":0.3468,"impliedVolPercentile":0.9802},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":22250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.12041,"shares":22250000,"dividePrice":0.2321,"high":37.86,"amplitude":0.011765,"preClose":37.4,"low":37.42,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.47,"eps":0,"divideRate":0.006194,"volume":586069,"delay":0,"ttmEps":0,"open":37.6,"prevYearClose":31.85,"prevWeekClose":37.44,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":38.02,"twentyDayClose":35.21,"sixtyDayClose":31.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157462487","title":"Tellgen Corporation Secures Six New Medical Device Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1157462487","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157462487?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:36","pubTimestamp":1788262589,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has announced that the company and its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently obtained six medical device registration certificates...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HART","BK1574","GDOC","RSPH","AGNG","BK1583","159883","MEDX","BK1100","LGHT","BK0046","IEIH","300642","MDEV","PTH","09996","BK0042","LNGR","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141380242","title":"Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1141380242","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141380242?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:20","pubTimestamp":1788261656,"startTime":"0","endTime":"0","summary":"On September 1st, medical stocks in both A-shares and Hong Kong markets bucked the market's downbeat trend, with related products such as Medical ETF Huabao (512170) and HK Stock Connect Medical ETF...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GDOC","MDEV","VXUS","09996","BK1100","MEDX","BK4585","PTH","AGNG","LNGR","159883","FLHK","KCAI","512170","HART","CXO","LGHT","WX","RSPH","BK1574","IEIH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237438978.USD","AGNG","IE0004086264.USD","LU0868494617.USD","LU0942090050.USD","DARP","LU1894683348.USD","LU2896262040.SGD","LU0106831901.USD","LU2471134523.USD","LTGO","LU0345770993.USD","LU2237443382.USD","FWD","LU1668664300.SGD","LU2471134796.USD","IBB","IE00BFXG1179.USD","BK4550","BK4127","RSPH","LU1868836591.USD","BK4552","IEIH","LU1868836914.USD","LU2237443895.HKD","BK4585","LU1868836757.USD","XT","LU0096364046.USD","LU1144417596.USD","SYNB","LNGR","LU0210536198.USD","BBC","BK4007","BK4516","GSX","LU2237443549.SGD","IE00B19Z3B42.SGD","BBP","IE00BSNM7G36.USD","BK4504","LU2237443622.USD","FHLC","IE0002270589.USD","IE0004091025.USD","JDOC","LU1868837136.USD","LU0251131958.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100056289","title":"Shandong Oriental Ocean Secures Regulatory Approval for Its Scavenger Receptor-A Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1100056289","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100056289?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:06","pubTimestamp":1788249995,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) announced that its wholly-owned subsidiary, Aviwe Bio-Tech Co., Ltd., has obtained the medical device registration certificate for the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0092","IEIH","MEDX","BK0213","LGHT","09996","BK0046","BK1574","GDOC","BK1100","MDEV","002086","HART","AGNG","LNGR","159883","PTH","RSPH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881767","title":"Actinogen Plans Major Share Placement to Bolster Funding Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881767","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:46","pubTimestamp":1788223606,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) just unveiled an update. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the code ACW,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","IBB","FHLC","BK4585","JDOC","LNGR","IEIH","XT","AGNG","DARP","FWD","BBP","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883783","title":"Incyte Reaches CMS Pact on Jakafi Medicaid Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883783","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883783?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:47","pubTimestamp":1788209252,"startTime":"0","endTime":"0","summary":"An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation said it has entered into an agreement with the U.S. Centers for Medica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incyte-reaches-cms-pact-on-jakafi-medicaid-pricing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4532","RSPH","BK4139","INCY","BK4550","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838898","title":"Teva to lower cost of select medicines for American patients covered by Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838898","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838898?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:15","pubTimestamp":1788207308,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva, announced a shared commitment with the Trump Administration to lower the cost of select medi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-to-lower-cost-of-select-medicines-for-american-patients-covered-by-medicaid-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-to-lower-cost-of-select-medicines-for-american-patients-covered-by-medicaid-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4585","TEVA","BK4588","BK4007","AFG","BK4117","LU2324357040.USD","BK4107","BK4596","RSPH","LU1983299246.USD","BK4559","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664700068","title":"Here's How to Invest Using a Winning Strategy That Offers a Spin on Traditional Stock Index Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664700068","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664700068?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:30","pubTimestamp":1788201000,"startTime":"0","endTime":"0","summary":"Invesco S&P 500 Equal Weigh","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPT","GPIX","XLE","XLB","VUG","RSPM","FELC",".SPX","HELO","FEBT","SPYM","FLCC","MSFT","ACLC","XLI","SCHG","GBXB","XLK","XLU","RSPG","NVDA","RSPS","VOOG","VYM","XLF","XLP","CFO","CPST","XLC","RSPF","XLRE","RSPD","XLV","LGH","XLY","AAPL","SPY","RSPN","RSPU","RSPH","GSUS","VOO","BKLC","RSPR","FDN","ISSXF","STT","RSPC","FLAO","CGUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131442769","title":"Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1131442769","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131442769?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:22","pubTimestamp":1788182577,"startTime":"0","endTime":"0","summary":"Eli Lilly and Co (NYSE: LLY) is set to acquire Merida Biosciences Inc. for up to $2.88 billion in cash, marking a strategic push into autoimmune and allergic disease treatments as the pharma giant...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBDS","FXH","NVOX","PINK","RSPH","XLVI","THNR","CURE","NVOC","IYH","TRUH","NVOH","PJP","MEDI","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115184678","title":"Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=1115184678","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115184678?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:40","pubTimestamp":1788165635,"startTime":"0","endTime":"0","summary":"Guangdong Hybribio Biotech Co., Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Chaozhou Kaipu Bio-Chemistry Co., Ltd. (referred to as \"Kaipu Chemistry\"), has recently obtained the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","BK0046","BK0042","GDOC","PTH","BK0132","159883","BK1574","RSPH","LGHT","LNGR","BK0239","HART","MEDX","09996","IEIH","BK1100","MDEV","BK1583","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FWD","BK4588","BK4139","FHLC","BK4007","IBB","SYNB","BK4539","BBP","AGNG","LNGR","JDOC","DARP","RSPH","XT","IEIH","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","RSPH","BK4585","TBXU","TAK","BK4139","SYNB","PINK","GNMX","XLVX","PSCH","IBB","BBP","BK4007","FRTY","TECB","MRNY","MEDI","IEIH","MRNX","LFSC","NVIB","LABU","PTGX","BK4588","IDNA","GDOC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IDNA","MRNX","XLVX","TECB","NVIB","LABU","TBXU","FRTY","SYNB","BBP","BMED","PINK","MRNY","BK4588","IEIH","PSCH","MEDI","IYH","RSPH","GNMX","IBB","GDOC","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","MRNX","IYH","FRTY","GNMX","MRNY","LABU","GDOC","IBB","MEDI","NVIB","PSCH","LFSC","BK4007","BBP","BK4588","BK4585","RSPH","BMED","TECB","TBXU","IDNA","TAK","SYNB","XLVX","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128151773","title":"India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=1128151773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128151773?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:56","pubTimestamp":1787954186,"startTime":"0","endTime":"0","summary":"India's weight-loss drug market is delivering a sobering lesson to the global pharmaceutical industry about market expectations. Despite large-scale generic production of GLP-1 medications and prices...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","XLVI","PJP","RSPH","JDOC","CURE","NVOC","LLII","MEDI","PINK","LLYX","FXH","OZEM","ELIL","NVOX","NVOH","MNDmain","NBDS","FHLC","TRUH","IYH","THNR","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065799","title":"PYC Therapeutics Files 2026 Corporate Governance Statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065799?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:28","pubTimestamp":1787909297,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an update. PYC Therapeutics Limited is an Australia-listed biotechnology company that disclose...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","FWD","BBP","BK4139","BK4007","LENZ","RSPH","BK4588","XT","LNGR","BK4585","IEIH","SYNB","AGNG","DARP","IBB","FHLC","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031648","title":"SomnoMed Tightens Insider Trading Rules With New Securities Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031648","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031648?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:19","pubTimestamp":1787872792,"startTime":"0","endTime":"0","summary":"The latest update is out from Somnomed Limited ( ($AU:SOM) ). SomnoMed Limited operates in the medical devices sector, focusing on oral appliance t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/somnomed-tightens-insider-trading-rules-with-new-securities-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/somnomed-tightens-insider-trading-rules-with-new-securities-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CURE","HART","BMED","IEHS","MEDI","RSPH","PINK","FHLC","AGNG","LNGR","MDTX","XT","HRTS","MDEV","GDOC","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192894793","title":"Recombinant Collagen Leader Faces Growth Challenges After Weak Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1192894793","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192894793?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:42","pubTimestamp":1787820126,"startTime":"0","endTime":"0","summary":"Jinbo Bio, a leading player in the recombinant collagen sector, recently published its interim report for the first half of 2026, revealing a notable setback in its growth trajectory. The financial...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HART","MEDX","BK1574","AGNG","BK1583","MDEV","GDOC","PTH","IEIH","LNGR","BK1100","RSPH","09996","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662872226","title":"Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2662872226","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662872226?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:37","pubTimestamp":1787801870,"startTime":"0","endTime":"0","summary":"Biotron ( ($AU:BIT) ) has shared an announcement. Biotron Limited, an ASX-listed Australian biotechnology company, focuses on antiviral drug develo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biotron-posts-wider-annual-loss-but-boosts-asset-backing-amid-material-uncertainty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biotron-posts-wider-annual-loss-but-boosts-asset-backing-amid-material-uncertainty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BK4585","XT","IBB","IEIH","LNGR","SYNB","RSPH","JDOC","BBP","BK4588","FHLC","DARP","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","MRNX","IEIH","IYH","FRTY","GNMX","MRNY","LABU","RHHBY","GDOC","IBB","MEDI","NVIB","PSCH","LFSC","BK4007","BBP","BK4588","BK4585","RSPH","BMED","TECB","TBXU","IDNA","03165","HRTS","SYNB","XLVX","PINK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":169,"code":"91000000","status":"200"}]}}